Sharp Therapeutics Corp.
SHRXF
$1.76
-$1.24-41.41%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 1,246.47% | 435.02% | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | 112.84% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | -- | 964.69% | -- | -- | |
|
|
|||||
| Total Current Assets | -- | 964.69% | -- | -- | |
| Net Property, Plant & Equipment | -- | -9.32% | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | 0.00% | -- | -- | |
| Total Assets | -- | 203.93% | -- | -- | |
|
|
|||||
| Total Accounts Payable | -- | -19.52% | -- | -- | |
| Total Accrued Expenses | -- | -72.53% | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | 55.16% | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -100.00% | -- | -- | |
| Total Other Current Liabilities | -- | -100.00% | -- | -- | |
| Total Current Liabilities | -- | -96.49% | -- | -- | |
|
|
|||||
| Total Current Liabilities | -- | -96.49% | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -3.70% | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -- | -88.91% | -- | -- | |
|
|
|||||
| Common Stock & APIC | -- | 385.94% | -- | -- | |
| Retained Earnings | -- | -14.86% | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -- | 116.93% | 94.23% | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -- | 116.93% | 94.23% | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -- | 116.93% | 94.23% | -- | |
|
|
|||||